Related Experiment Video

Updated: Jun 3, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Tacrolimus in the treatment of ocular diseases

Jiajie Zhai1, Jianjun Gu, Jin Yuan

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|March 30, 2011
PubMed

Insights

Tacrolimus (FK506) is an effective immunomodulator for treating various eye conditions, including graft rejection and uveitis. It offers a safe alternative to toxic immunosuppressive therapies for ocular surface disorders.

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Tacrolimus (FK506) has been a systemic immunomodulator for over 20 years.
  • Its mechanisms of action have been extensively studied.
  • Ocular surface disorders often involve immune-based inflammation.

Purpose of the Study:

  • To investigate the efficacy of systemic and topical tacrolimus for ocular surface disorders.
  • To evaluate tacrolimus as a treatment for immune-mediated eye conditions.
  • To explore tacrolimus as an alternative to toxic immunosuppressive therapies.

Main Methods:

  • Review of studies investigating systemic and topical tacrolimus.
  • Analysis of tacrolimus efficacy in various ocular conditions.
  • Assessment of safety and tolerability compared to existing treatments.

Main Results:

  • Tacrolimus demonstrated efficacy in treating corneal graft rejection.
  • It was effective for inflammatory conjunctival and corneal diseases.
  • Tacrolimus showed promise in managing uveitis and graft-versus-host disease.

Conclusions:

  • Ophthalmic or systemic tacrolimus is a valuable treatment for refractory ocular surface disorders.
  • Tacrolimus serves as a safe adjunct or replacement for toxic immunosuppressive therapies.
  • Further research supports tacrolimus in managing immune-mediated ocular conditions.

More Related Videos

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...